Absence of gadolinium deposits in the peritoneal membrane of patients with encapsulating peritoneal sclerosis

Nephrology Dialysis Transplantation

Volumn 25, Issue 4, 2010, Pages 1329-1334

  Goffin, Eric ^a   Schroeder, Josef A ^b   Weingart, Christian ^b   Decleire, Pierre Yves ^a   Cosyns, Jean Pierre ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Encapsulating peritoneal sclerosis; Gadolinium; Magnetic resonance imaging; Nephrogenic systemic fibrosis; Peritoneal dialysis

Indexed keywords

AZATHIOPRINE; CD34 ANTIGEN; CD68 ANTIGEN; CYCLOSPORIN; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE; IRON; MEROPENEM; METAL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TAMOXIFEN; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BACTERIAL PERITONITIS; CASE REPORT; CONNECTIVE TISSUE; CONTROLLED STUDY; DRUG DOSE INCREASE; ENCAPSULATING PERITONEAL SCLEROSIS; ENERGY FILTERED TRANSMISSION ELECTRON MICROSCOPY; FEMALE; FOLLOW UP; GASTRIC SUCTION; HUMAN; HYPOTHESIS; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; INTESTINE LOOP; INTESTINE WALL; KIDNEY FAILURE; LONG TERM CARE; MACROPHAGE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENTERAL NUTRITION; PERITONEAL BIOPSY; PERITONEAL CAVITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SCLEROSIS; SINGLE DRUG DOSE; SMALL INTESTINE RESECTION; VASCULAR ENDOTHELIUM; COMPUTER ASSISTED TOMOGRAPHY; EXPOSURE; HISTOPATHOLOGY; HUMAN TISSUE; KIDNEY TRANSPLANTATION; PERITONEAL FIBROSIS; TRACE METAL BLOOD LEVEL; ULTRASTRUCTURE; CELL MEMBRANE; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; DRUG EFFECT; MIDDLE AGED; NEPHROGENIC SYSTEMIC FIBROSIS; PATHOLOGY; PERITONEUM;

ADULT; CELL MEMBRANE; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEPHROGENIC FIBROSING DERMOPATHY; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEUM;

EID: 77950250531     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp664     Document Type: Article

References (43)

1. Chin AI, Yeun JY. Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysis. Am J Kidney Dis 2006; 47: 697-712
2. Summers AM, Clancy MJ, Syed F, et al. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int 2005; 68: 2381-2388
3. Balasubramaniam G, Brown EA, Davenport A, et al. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant 2009; 24: 3209-3215
4. Perazella MA. Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol 2009; 4: 461-469
5. Fieren MWJA, Betjes MGH, Korte MR, et al. Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit Dial Int 2007; 27: 619-624
6. Goffin E, Decleire PY. Does the incidence of encapsulating peritoneal sclerosis increase after renal transplantation? Perit Dial Int 2008; 28: S5
7. Korte MR, Yo M, Betjes MGH, et al. Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation. Ne-phrol Dial Transplant 2007; 22: 2412-2414
8. Cowper SE, Robin HS, Steinberg SM, et al. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000; 356: 1000-1001
9. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibro-sis? Nephrol Dial Transplant 2006; 12: 3604-3605
10. Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006; 17: 2359-2362
11. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007; 243: 148-157
12. High WA, Ayers RA, Chandler J, et al. Cowper SE gadolinium is detectable within the tissue of patients with nephrogenic systemic fibro-sis. J Am Acad Dermatol 2007; 56: 21-26
13. High WA, Ayers RA, Cowper SE. Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 2007; 56: 710-712
14. Schroeder JA, Weingart C, Coras B, et al. Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease. Clin J Am Soc Nephrol 2008; 3: 968-975
15. Swaminathan S, Horn TD, Pellowski D, et al. Nephrogenic systemic fibrosis, gadolinium, and iron mobilization. N Engl J Med 2007; 357: 720-722
16. Swaminathan S, High WA, Ranville J, et al. Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis. Kidney Int 2008; 73: 1413-1418
17. Kay J, Bazari H, Avery LL, et al. Case records of the Massachusetts General Hospital. Case 6-2008. A 46-year-old woman with renal failure and stiffness of the joints and skin. N Engl J Med 2008; 358: 827-838
18. Prchal D, Holmes DT, Levin A. Nephrogenic systemic fibrosis: the story unfolds. Kidney Int 2008; 73: 1135-1137
19. Cowper SE, Su LD, Bhawan J, et al. Nephrogenic fibrosing dermo-pathy. Am J Dermatopathol 2001; 23: 383-393
20. Lim YL, Lee HY, Low SC, et al. Possible role of gadolinium in ne-phrogenic systemic fibrosis: report of two cases and review of the literature. Clin Exp Dermatol 2007; 32: 353-358
21. Murashima M, Drott HR, Carlow D, et al. Removal of gadolinium by peritoneal dialysis. Clin Nephrol 2008; 69: 368-372
22. Tsai CW, Chao CC, Wu VC, et al. Nephrogenic fibrosing dermopathy in a peritoneal dialysis patient. Kidney Int 2007; 72: 1294
23. Othersen JB, Maize JC, Woolson RF, et al. Nephrogenic systemic fi-brosis after exposure to gadolinium in patients with renal failure. Ne-phrol Dial Transplant 2007; 22: 3179-3185
24. Marckmann P, Skov L, Rossen K, et al. Case-control study of gado-diamide-related nephrogenic systemic fibrosis. Nephrol Dial Transplant 2007; 22: 3174-3178
25. Reimer L, Deininger C, Egerton RF, et al. Electron-Filtering Transmission Electron Microscopy. Berlin: Springer, 1995
26. Leapman RD, Sun SQ, Hunt JA, et al. Biological electron energy loss spectroscopy in the field-emission scanning transmission electron microscope. Scanning Microsc Suppl 1994; 8: 245-258 [discussion 258-259]
27. Egerton RF. Electron Energy-Loss Spectroscopy in the Electron Microscope. New York: Plenum, 1986
28. Simon GT, Heng YM. Electron energy loss spectroscopic imaging in biology. Scanning Microsc 1988; 2: 257-266
29. Egerton RF. New techniques in electron energy-loss spectroscopy and energy-filtered imaging. Micron 2003; 34: 127-139
30. Egerton RF. Limits to the spatial, energy and momentum resolution of electron energy-loss spectroscopy. Ultramicroscopy 2007; 107: 575-586
31. Keast VJ, Bosman M. New developments in electron energy loss spectroscopy. Microsc Res Tech 2007; 70: 211-219
32. Kapp N, Studer D, Gehr P, et al. Electron energy-loss spectroscopy as a tool for elemental analysis in biological specimens. In: K John (ed). Electron Microscopy, Methods and Protocols. 2nd ed. Totowa: Humana, 2007; 431-447
33. Kapp N, Kreyling W, Schulz H. Electron energy loss spectroscopy for analysis of inhaled ultrafine particles in rat lungs. Microsc Res Tech 2004; 63: 298-305
34. Rothen-Rutishauser BM, Schurch S, Haenni B, et al. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ Sci Technol 2006; 40: 4353-4359
35. Geiser M, Rothen-Rutishauser B, Kapp N, et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 2005; 113: 1555-1560
36. Hirai K, Pan J, Shimada H, et al. Cytochemical energy-filtering transmission electron microscopy of mitochondrial free radical formation in paraquat cytotoxicity. J Electron Microsc (Tokyo) 1999; 48: 289-296
37. Schlotzer-Schrehardt U, Kortje KH, Erb C. Energy-filtering transmission electron microscopy (EFTEM) in the elemental analysis of pseu-doexfoliative material. Curr Eye Res 2001; 22: 154-162
38. Jonas L, Fulda G, Kroning G, et al. Electron microscopic detection of tin accumulation in biliopancreatic concrements after induction of chronic pancreatitis in rats by di-n-butyltin dichloride. Ultrastruct Pathol 2002; 26: 89-98
39. Combet S, Miyata T, Moulin P, et al. Vascular proliferation and enhanced expression of endothelial nitric oxyde synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Ne-phrol 2000; 11: 717-728
40. Di Paolo N, Sacchi G. Atlas of peritoneal histology. Perit Dial Int 2000; 20: S5-S96
41. Idee JM, Port M, Raynal I, et al. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 2006; 20: 563-576
42. Kovesdy CP. Iron and clinical outcomes in dialysis and non-dialysis-dependent chronic kidney disease patients. Adv Chronic Kidney Dis 2009; 16: 109-116
43. Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 2006; 1: S4-S8